Cohen Neil Harris

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 12% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -71%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Cohen Neil Harris's trades of Chemomab Therapeutics Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-18 2022-11-16
S Sale
73,037 +6.2%
478.06
US$976,906 		73,037 +6.2% 478.06 US$976,906
2022-05-19 2022-05-18
B Purchase
10,518 -14.9%
194.10
US$4,446,256 		10,518 -14.9% 194.10 US$4,446,256
2022-03-15 2022-03-14
B Purchase
73,394 +23.8%
58.96
US$1,684,918 		73,394 +23.8% 58.96 US$1,684,918
2022-03-15 2022-03-14
B Purchase
2,000 +31.2%
4.30
US$8,600 		2,000 +31.2% 4.30 US$8,600
2022-03-15 2022-03-14
B Purchase
2,000 +45.4%
4.20
US$8,400 		2,000 +45.4% 4.20 US$8,400
2021-12-08 2021-12-06
B Purchase
2,000 +83.0%
7.43
US$14,860 		2,000 +83.0% 7.43 US$14,860
2021-03-26 2021-03-16
B Purchase
2,409 +inf%
41.51
US$99,998 		2,409 +inf% 41.51 US$99,998